Jaguar Health (JAGX) Enterprise Value (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Enterprise Value of -$11.6 million for Q1 2026, down 75.22% year-over-year from -$47.0 million in Q1 2025, and down 26.08% quarter-over-quarter from -$9.2 million in Q4 2025.
Jaguar Health (JAGX) Enterprise Value (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Enterprise Value for 13 consecutive years, with -$11.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 75.22% year-over-year to -$11.6 million; the TTM figure through Mar 2026 stood at -$11.6 million (down 75.22% YoY), while the FY2025 annual figure was -$9.2 million, down 4.98% from the prior year.
- Enterprise Value eased to -$11.6 million in Q1 2026 per JAGX's latest filing, from -$9.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$3.2 million in Q3 2023 and bottomed at -$17.4 million in Q1 2022.
- Historically, Enterprise Value has averaged -$9.5 million across 5 years, with a median of -$9.0 million in 2022.
- Annual changes were most pronounced in 2024 — Enterprise Value plunged 334.79% — and 2025, when it surged 79.76%.
- Jaguar Health's Enterprise Value stood at -$5.2 million in 2022, then dropped by 24.99% to -$6.5 million in 2023, then sank by 34.59% to -$8.8 million in 2024, then fell by 4.98% to -$9.2 million in 2025, then dropped by 26.08% to -$11.6 million in 2026.
- Business Quant data shows JAGX's Enterprise Value at -$11.6 million in Q1 2026, -$9.2 million in Q4 2025, and -$4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.12 Bn |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | -11.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.64 Mn |
| Dec 31, 2025 | -9.23 Mn |
| Sep 30, 2025 | -4.80 Mn |
| Jun 30, 2025 | -3.32 Mn |
| Mar 31, 2025 | -6.64 Mn |
| Dec 31, 2024 | -8.79 Mn |
| Sep 30, 2024 | -13.78 Mn |
| Jun 30, 2024 | -16.38 Mn |
| Mar 31, 2024 | -11.85 Mn |
| Dec 31, 2023 | -6.53 Mn |
| Sep 30, 2023 | -3.17 Mn |
| Jun 30, 2023 | -8.44 Mn |
| Mar 31, 2023 | -14.06 Mn |
| Dec 31, 2022 | -5.23 Mn |
| Sep 30, 2022 | -10.61 Mn |
| Jun 30, 2022 | -8.97 Mn |
| Mar 31, 2022 | -17.39 Mn |
| Dec 31, 2021 | -16.81 Mn |
| Sep 30, 2021 | -12.38 Mn |
| Jun 30, 2021 | -9.92 Mn |